Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Cavalloni · SciRah

Researcher profile · Semantic Scholar

C. Cavalloni

Share profile

C. Cavalloni — researcher profile on SciRah

h-index: 19
Works: 49
Citations: 1,608

Most-cited papers

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
E. Rumi, D. Pietra, C. Pascutto, P. Guglielmelli +19 more
2014Blood402 citations Open access
Semantic Scholar
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
D. Pietra, E. Rumi, V. Ferretti, C. D. Di Buduo +16 more
2015Leukemia275 citations Open access
Semantic Scholar
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
L. Arcaini, S. Zibellini, E. Boveri, R. Riboni +12 more
2012Blood162 citations
Semantic Scholar
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.
E. Rumi, A. Harutyunyan, D. Pietra, Jelena D. Milosevic +13 more
2014Blood91 citations Open access
Semantic Scholar
Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia.
G. Finazzi, A. Carobbio, P. Guglielmelli, C. Cavalloni +6 more
2014Blood79 citations Open access
Semantic Scholar
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria
E. Rumi, E. Boveri, M. Bellini, D. Pietra +12 more
2017OncoTarget58 citations Open access
Semantic Scholar
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
P. Guglielmelli, A. Carobbio, E. Rumi, V. De Stefano +11 more
2020Blood Cancer Journal55 citations Open access
Semantic Scholar
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
E. Rumi, Jelena D. Milosevic, D. Selleslag, I. Casetti +10 more
2015Annals of Hematology53 citations
Semantic Scholar
LNK mutations in familial myeloproliferative neoplasms.
E. Rumi, A. Harutyunyan, D. Pietra, J. D. Milosevic Feenstra +10 more
2016Blood46 citations
Semantic Scholar
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia
E. Rumi, I. Bertozzi, I. Casetti, E. Roncoroni +11 more
2015Haematologica39 citations Open access
Semantic Scholar
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
B. Mora, T. Giorgino, P. Guglielmelli, E. Rumi +24 more
2018Haematologica36 citations Open access
Semantic Scholar
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
C. Pecquet, Nicolas Papadopoulos, Thomas Balligand, I. Chachoua +38 more
2022Blood34 citations Open access
Semantic Scholar
Secreted Mutant Calreticulins As Rogue Cytokines Trigger Thrombopoietin Receptor Activation Specifically in CALR Mutated Cells: Perspectives for MPN Therapy
C. Pecquet, Thomas Balligand, I. Chachoua, Anita Roy +26 more
2018Blood34 citations
Semantic Scholar
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis
A. Carobbio, P. Guglielmelli, E. Rumi, C. Cavalloni +8 more
2020Blood Cancer Journal28 citations Open access
Semantic Scholar
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.
M. Maffioli, T. Giorgino, B. Mora, A. Iurlo +24 more
2019Blood Advances25 citations Open access
Semantic Scholar
Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms
E. Rumi, S. Zibellini, E. Boveri, C. Cavalloni +10 more
2019American journal of hematology/oncology25 citations Open access
Semantic Scholar
Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera
I. Bertozzi, E. Rumi, C. Cavalloni, M. Cazzola +2 more
2018American journal of hematology/oncology25 citations Open access
Semantic Scholar
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
A. Tedeschi, A. Frustaci, F. Mauro, A. Chiarenza +27 more
2021Blood Advances21 citations Open access
Semantic Scholar
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
B. Mora, E. Rumi, P. Guglielmelli, D. Barraco +22 more
2019Cancer Medicine21 citations Open access
Semantic Scholar
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia.
B. Mora, T. Giorgino, P. Guglielmelli, E. Rumi +21 more
2018Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis17 citations
Semantic Scholar
Diagnosis and management of prefibrotic myelofibrosis
E. Rumi, Emanuela Sant'Antonio, E. Boveri, D. Pietra +4 more
2018Expert Review of Hematology16 citations
Semantic Scholar
Facing erythrocytosis: Results of an international physician survey
E. Rumi, M. McMullin, C. Harrison, M. Ellis +11 more
2019American journal of hematology/oncology15 citations Open access
Semantic Scholar
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group
B. Mora, P. Guglielmelli, E. Rumi, M. Maffioli +26 more
2019American journal of hematology/oncology13 citations Open access
Semantic Scholar
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin’s B lymphoma: a single center prospective clinico-pathological study
A. Michelerio, C. Tomasini, G. Fiandrino, M. De Amici +8 more
2023Frontiers in Medicine12 citations Open access
Semantic Scholar
Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms
C. Cavalloni, E. Rumi, V. Ferretti, D. Pietra +9 more
2017OncoTarget11 citations Open access
Semantic Scholar
Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib
E. Rumi, Emanuela Sant'Antonio, C. Cavalloni, G. Comolli +12 more
2020Hematological Oncology8 citations
Semantic Scholar
Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia
J. Paludo, J. Abeykoon, Nirosha Perera, S. Sarosiek +17 more
2025American journal of hematology/oncology5 citations
Semantic Scholar
Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study
M. Varettoni, S. Zibellini, M. Merli, D. Drandi +15 more
2022Hematological Oncology3 citations Open access
Semantic Scholar
Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma
C. Cavalloni, M. Varettoni, S. Rattotti, L. Arcaini
2021Expert Opinion on Pharmacotherapy2 citations
Semantic Scholar
PS1458 RISK FACTORS AND OUTCOME OF ACUTE MYELOID LEUKEMIA SECONDARY TO POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: AN ANALYSIS OF THE MYSEC COHORT
B. Mora, P. Guglielmelli, E. Rumi, M. Maffioli +23 more
2019HemaSphere2 citations Open access
Semantic Scholar
IGHV AND TP53 MUTATIONAL STATUS AT DIAGNOSIS MAY HAVE IMPACT ON OUTCOME IN PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA
E. Cappello, S. Zibellini, C. Varraso, V. Ferretti +19 more
2025Hematological Oncology1 citations
Semantic Scholar
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature
I. Del Giudice, L. Cappelli, J. Delgado, C. Niemann +25 more
2023British Journal of Haematology1 citations Open access
Semantic Scholar
Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience
M. Merli, A. Anastasia, M. Deodato, L. Nassi +22 more
2023Blood1 citations Open access
Semantic Scholar
P1256: A NOVEL DROP-OFF DIGITAL PCR ASSAY FOR CXCR4 MUTATION SCREENING IN IGM GAMMOPATHIES: FIRST DATA FROM THE FONDAZIONE ITALIANA LINFOMI BIO-WM STUDY
D. Drandi, M. Ferrante, S. Zibellini, L. Marcheselli +24 more
2022HemaSphere1 citations Open access
Semantic Scholar
Prognostic impact of depth of response in Waldenström macroglobulinemia patients treated with fixed duration chemoimmunotherapy.
Nirosha D. Perera, J. Abeykoon, J. Castillo, J. Gustine +13 more
20211 citations
Semantic Scholar
Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib
E. Rumi, C. Cavalloni, G. Comolli, V. Ferretti +9 more
2019Blood1 citations
Semantic Scholar
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin
D. Pietra, E. Rumi, C. Milanesi, C. D. Di Buduo +11 more
20141 citations
Semantic Scholar
Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.
G. Roccuzzo, P. Fava, S. Rupoli, E. Morsia +26 more
2026British Journal of Dermatology0 citations Open access
Semantic Scholar
Regression of T-LGL leukemia in a patient treated with sildenafil for pulmonary hypertension.
G. Favrin, E. Cappello, S. Rattotti, C. Picone +6 more
2026Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis0 citations
Semantic Scholar
Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.
E. Cappello, M. Lucioni, E. Boveri, V. Ferretti +12 more
2026Haematologica0 citations Open access
Semantic Scholar
Assessment of minimal residual disease with droplet digital polymerase chain reaction for BRAF V600E mutation in patients with hairy cell leukemia treated with purine analogs
G. Favrin, C. Varraso, S. Zibellini, E. Cappello +9 more
2025Blood0 citations
Semantic Scholar
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next‐generation sequencing in 211 patients with early stage chronic lymphocytic leukemia
M. Varettoni, E. Orlandi, S. Zibellini, M. Rossi +12 more
2021American journal of hematology/oncology0 citations Open access
Semantic Scholar
Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting
M. Varettoni, S. Mangiacavalli, S. Rattotti, C. Cartia +15 more
2021Leukemia and Lymphoma0 citations
Semantic Scholar
PB2212 FACING ERYTHROCYTOSIS: RESULTS OF AN INTERNATIONAL PHYSICIANS’ SURVEY
E. Rumi, M. McMullin, C. Harrison, M. Ellis +10 more
2019HemaSphere0 citations Open access
Semantic Scholar
PF669 RUXOLITINIB TREATMENT AND RISK OF B-CELL LYMPHOMAS IN MYELOPROLIFERATIVE NEOPLASMS
C. Cavalloni, E. Rumi, S. Zibellini, E. Boveri +10 more
2019HemaSphere0 citations Open access
Semantic Scholar
Validation of the International Prognostic Score for Thrombosis in Essential Thrombocythemia (IPSET) in Patients with Pre-Fibrotic Primary Myelofibrosis
P. Guglielmelli, A. Carobbio, E. Rumi, V. De Stefano +11 more
2019Blood0 citations Open access
Semantic Scholar
Solid Tumors in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: A Study on 2220 Patients
B. Mora, E. Rumi, P. Guglielmelli, D. Barraco +22 more
2018Blood0 citations Open access
Semantic Scholar
myelofibrosis in primary MPL , or CALR , JAK2 Clinical effect of driver mutations of
M. Cazzola, V. Rosti, F. Cervantes, G. Barosi +12 more
20140 citations
Semantic Scholar
Prognostic signi ﬁ cance of monotypic plasma cell in ﬁ ltration of the bone marrow in patients with Waldenström macroglobulinemia
E. Cappello, M. Lucioni, E. Boveri, V. Ferretti +16 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Rumi×30
Invite
E. Rumi — researcher profile on SciRah
M. Cazzola×26
Invite
M. Cazzola — researcher profile on SciRah
D. Pietra×22
Invite
D. Pietra — researcher profile on SciRah
L. Arcaini×19
Invite
L. Arcaini — researcher profile on SciRah

×18

Invite

V. Ferretti — researcher profile on SciRah

Invite

I. Casetti — researcher profile on SciRah

Invite

E. Boveri — researcher profile on SciRah

M. Varettoni×13

Invite

M. Varettoni — researcher profile on SciRah

P. Guglielmelli×12

Invite

P. Guglielmelli — researcher profile on SciRah

Invite

T. Barbui — researcher profile on SciRah

A. Vannucchi×11

Invite

A. Vannucchi — researcher profile on SciRah

S. Zibellini×11

Invite

S. Zibellini — researcher profile on SciRah